Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcγRI, FcγRIII, and FcγRIV

Despite the demonstrated clinical efficacy of CD20 monoclonal antibody (mAb) for lymphoma therapy, the in vivo mechanisms of tumor depletion remain controversial and variable. To identify the molecular mechanisms responsible for lymphoma killing by CD20 mAb in a homologous system amenable to mechani...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Minard-Colin, Veronique, Xiu, Yan, Poe, Jonathan C., Horikawa, Mayuka, Magro, Cynthia M., Hamaguchi, Yasuhito, Haas, Karen M., Tedder, Thomas F.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Hematology 2008
Teme:
Immunobiology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2515149/
https://ncbi.nlm.nih.gov/pubmed/18495955
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-01-135160
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items